Search Within

Ellin Berman

  1. "Sloan Kettering Institute Faculty"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (14)
  3. Conference Paper (2)
Groups
  1. Adult Leukemia (41)
  2. Center for Hematologic Malignancies (41)
  3. Department of Medicine (41)
  4. Hematologic Malignancies, Division of (41)
  5. Sloan Kettering Institute Faculty (41)
  6. Molecular Pharmacology and Chemistry Program Faculty (37)

More Groups

People
  1. Bayard Clarkson (25)
  2. Timothy Gee (21)
  3. David Scheinberg (15)
  4. Peter Maslak (13)
  5. Sanford Kempin (13)
  6. Mark Weiss (10)

More People

Years
  1. 2016 (1)
  2. 2011 (1)
  3. 2010 (1)
  4. 2008 (1)
  5. 2006 (2)
  6. 2005 (1)

More Years

Publications
  1. Blood (16)
  2. Journal of Clinical Oncology (8)
  3. Leukemia (5)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  5. Seminars in Oncology (2)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. American Society of Clinical Oncology (8)
  3. Nature Publishing Group (6)
  4. American Association for Cancer Research (3)
  5. Elsevier Inc. (2)
  6. Elsevier Ltd (1)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
    Journal Article

    Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
    Leukemia (2008)

    Fulltext@MSK | Save
  • Treatment outcome after induction chemotherapy before allogeneic hematopoietic SCT in patients with advanced MDS
    Meeting Abstract

    Ramos, C. A.; Jakubowski, A. A.; Boulad, F.; Papadopoulos, E. B.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Berman, E.; O'Reilly, R. J.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Induction with combined modality therapy followed by immunomodulated post remission therapy for newly diagnosed acute myeloid leukemia (AML)
    Meeting Abstract

    Gupta, S.; Weiss, M. A.; Jurcic, J. G.; Chanel, S.; Wilson, B. A.; Biederman, E.; Berman, E.; Scheinberg, D. A.; Maslak, P. G.
    Blood (2005)

    Fulltext@MSK | Save
  • Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL)
    Journal Article

    Berman, E.; Jhanwar, S.; McBride, M.; Strife, A.; Wisniewski, D.; Lambek, C.; Clarkson, B.
    Leukemia Research (2000)

    Fulltext@MSK | Save
  • Phase I study of a single high dose of liposomal daunorubicin combined with high dose cytarabine for adult patients with relapsed/refractory acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Cathcart, K.; Heaney, M.; Berman, E.; Soignet, S.; Scheinberg, D.; Ward, S.
    Blood (2000)

    Fulltext@MSK | Save
  • High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML
    Meeting Abstract

    Maslak, P.; Weiss, M.; Jurcic, J.; Jimenez, J.; Berman, E.; Golde, D.; Scheinberg, D.
    Blood (1998)

    Fulltext@MSK | Save